SCHEMBL13487515

SCHEMBL13487515

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4ccncc4)c4ccc(-c5ccccc5)cc34)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 4/20 0.41
PIK3CA P42336 1/20 0.40
IMPDH2 P12268 2/20 0.40
MKNK1 Q9BUB5 1/20 0.39
NOTUM Q6P988 1/20 0.36
CHEK1 O14757 3/20 0.33
ALK Q9UM73 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
ROCK2 O75116 2/20 0.32
CDK2 P24941 2/20 0.32
CDC7 O00311 1/20 0.32
MAP4K4 O95819 1/20 0.32
PRKACA P17612 1/20 0.32
GSK3B P49841 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
MAPK14 Q16539 1/20 0.32
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487896 0.93 PDK2 (0.46) PDK2PIK3CAIMPDH2MKNK1NOTUM
SCHEMBL13487720 0.93 PDK2 (0.43) PDK2PIK3CAIMPDH2MKNK1HSD17B1
SCHEMBL13487656 0.90 MAPK9 (0.37) PDK2CHEK1HSD17B1HSD17B2MAPK14
SCHEMBL15977559 0.89 PDK2 (0.49) PDK2PIK3CAIMPDH2MKNK1ROCK2
SCHEMBL13488126 0.89 PDK2 (0.46) PDK2PIK3CAIMPDH2MKNK1HSD17B1
SCHEMBL13487512 0.88 PDK2 (0.42) PDK2PIK3CACHEK1ALKHSD17B1
SCHEMBL13487513 0.88 PDK2 (0.33) PDK2PIK3CA
SCHEMBL13487445 0.88 MAPT (0.39) PDK2IMPDH2MAPK14
SCHEMBL13487514 0.88 PDK2 (0.35) PDK2PIK3CAIMPDH2MKNK1MAPK14
SCHEMBL13487599 0.87 MAPK11 (0.38) PDK2HSD17B1HSD17B2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PDK2 1456/4885PIK3CA 3662/4885IMPDH2 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.